Atlas Trials

A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden

Clinical trial NCT03903094 · COMPLETED

Trial details

NCT number
NCT03903094
Sponsor
Astellas Pharma Singapore Pte. Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Overactive Bladder (OAB)
Start date
2019-03-07
Primary completion
2022-05-06
Enrollment
6295279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.